Sophie Vo

I am a Senior Associate in the Intellectual Property Group in London with a particular focus on the life sciences and healthcare sectors.

My practice consists of both non-contentious and contentious IP matters across the life sciences/healthcare product-to-market cycle, which is complemented by my STEM background in Pharmacology.

In relation to IP enforcement, my experience includes patent litigation in the English High Court and Federal Court of Australia. These cases involved mRNA vaccines, electrochemical treatments, biopharmaceuticals and medical devices.

I am experienced with advising on a variety of complex commercial and corporate matters that are IP-rich and that intersect with regulatory issues, including research collaborations, licensing arrangements, and manufacturing and supply deals. This work tends to consist of advising on the creation and ownership of IP as well as the rights to use it. It also tends to require knowledge of regulatory and product compliance issues. I have worked on transactions that concern pharmaceuticals, medical devices, software, agrochemicals and healthcare services provision.

I also advise on life sciences and healthcare regulatory issues, such as requirements for bringing medicines and medical devices to market as well as advertising and promotional clearances.

I am an editor of Bird & Bird Patent Hub blog, and a co-author of the 'Guide to EU and UK Pharmaceutical Regulatory Law' (Kluwer Law International), along with my European/UK colleagues.

• BioNTech and Pfizer v CureVac [2024] EWHC 2538 (Pat)
• InterDigital Technology Corporation v Guangdong Oppo Mobile Telecommunications & others (HP-2021-000047)
• Vector Corrosion Technologies Limited v E-Chem Technologies Ltd [2022] FCA 188